![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
China Medical Technologies ADS, Each Representing 10 Ordinary Shares (MM) | NASDAQ:CMED | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.82 | 0 | 01:00:00 |
UNITED STATES
SECURITIES EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Continued on following pages Page 1 of 5 Pages
SCHEDULE 13G
CUSIP No.: 169483104 Page 2 of 5 Pages ................................................................................ 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). NORGES BANK (THE CENTRAL BANK OF NORWAY) ................................................................................ 2. Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] N/A ................................................................................ 3. SEC Use Only ................................................................................ 4. Citizenship or Place of Organization NORWAY ................................................................................ Number of 5. Sole Voting Power 1,626,530 Shares Beneficially ................................................................ Owned by Each Reporting 6. Shared Voting Power 0 Person With ................................................................ 7. Sole Dispositive Power 30,041 ................................................................ 8. Shared Dispositive Power 0 ................................................................................ 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,626,530 ................................................................................ 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) N/A ................................................................................ 11. Percent of Class Represented by Amount in Row (9) 5.07% based on 32,106,666 American Depositary Receipts issued ................................................................................ 12. Type of Reporting Person: OO |
CUSIP No.: 169483104 Page 3 of 5 Pages Item 1(a). Name of Issuer: China Medical Technologies Inc. (the "Issuer"). Item 1(b). Address of Issuer's Principal Executive Offices: 24 Yong Chang North Road Beijing Economic-Technological Development Area Beijing 100176, Republic of China Item 2(a). Name of Person Filing: This Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"): NORGES BANK (CENTRAL BANK OF NORWAY) Item 2(b). Address of Principal Business Office or, if None, Residence: Bankplassen 2 PO Box 1179 Sentrum NO 0107 Oslo Norway Item 2(c). Citizenship: Norwegian Item 2(d). Title of Class of Securities: American Depositary Receipt Item 2(e). CUSIP Number: 169483104 Item 3. If This Statement is Filed Pursuant to ss.ss.240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a: This Item 3 is not applicable. Item 4. Ownership: Item 4(a) Amount Beneficially Owned As of September 14, 2009, Norges Bank may be deemed to be the benficial owner of 1,626,530 shares of American Depositary Receipt. Item 4(b) Percent of Class: The number of Shares which Norges Bank may be deemed to be the beneficial owner constitutes approximately 5.07% of the total number of American Depositary Receips outstanding (based upon information provided by the Issuer in its most recently filed quarterly report), there is 32,106,666 shares of American Depositary Receipts outstanding). All shares held by Norges Bank are in the form of American Depositary Receipts, each representing 10 ordinary shares. |
Page 4 of 5 Pages
Item 4(c) Number of Shares of which such person has:
NORGES BANK (CENTRAL BANK OF NORWAY)
(i) Sole power to vote or direct the vote: 1,626,530
(ii) Shared power to vote or direct the vote: 0
(iii) Sole power to dispose or direct the disposition of: 30,041
(iv) Shared power to dispose or direct the disposition of: 0
Item 5. Ownership of Five Percent or Less of a Class:
This Item 5 is not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another
Person:
This Item 6 is not applicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company:
This Item 7 is not applicable.
Item 8. Identification and Classification of Members of the Group:
This Item 8 is not applicable.
Item 9. Notice of Dissolution of Group:
This Item 9 is not applicable.
Item 10. Certification:
By signing below each of the Reporting Persons certifies that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
Page 5 of 5 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
NORGES BANK
Date: September 18, 2009 By: /s/ Jonas Lexmark ---------------------- Name: Jonas Lexmark Title: Analyst |
1 Year China Medical Chart |
1 Month China Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions